IRS1 has been flagged as a risk locus for insulin resistance (Rung et al., 2009) and type II diabetes (Rung et al., 2009; Voight et al., 2010), and also several cancers (Slattery et al., 2004). Here, IRS1 is linked to type 2 diabetes mellitus.